Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Cobicistat

A pharmacokinetic enhancer that inhibits the liver's CYP3A enzymes: approved in 2012 within fixed-dose combinations against HIV, it keeps other antiretrovirals in the blood for longer. This family brings together the active ingredient, labelled standards and other impurities.

Did you know?It has no activity against HIV at all: it was obtained by modifying ritonavir, an antiviral that was already used at low doses precisely as a 'booster' for other drugs.

CobicistatGo to the active ingredient →
CobicistatActive ingredientCobicistatCat. No. P-C233-001CAS 1004316-88-4
Cobicistat-d8Isotopically labelledCobicistat-d8Cat. No. P-C233-002CAS 2699607-48-0

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.